See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

Veno-arterial extracorporeal membrane oxygenation (ECMO) is a strong mechanical
circulatory device for patients with hemodynamic deterioration due to cardiogenic shock, but …

Cardiogenic shock (CS) is a life-threatening condition characterized by a state of inadequate
systemic tissue perfusion caused by cardiac dysfunction. When to implement, change, or …

Abstract OBJECTIVES The HeartWare HVAD (HW) and the HeartMate3 (HM3) are presently
the most commonly used continuous-flow left ventricular assist devices worldwide. We …

Background The Abiomed Impella 5.5 (Danvers, MA) is a newly developed axial flow
transaortic cardiac support device mounted on a 9 Fr steering catheter with a 21 Fr pump …

OBJECTIVES Short-term mechanical circulatory support is a life-saving treatment for acute
cardiogenic shock (CS). This multicentre study investigates the preoperative predictors of 30 …

Aims We aimed to detail the early clinical experience with pVAD 5.5 at a large academic
medical centre. Impella® 5.5 (Abiomed) is a temporary peripherally inserted left ventricular …

Advanced heart failure (HF) represents a public health priority due to the increase of affected
patients and the meaningful mortality. Durable mechanical circulatory support (MCS) and …

Left ventricular assist devices (LVADs) are increasingly used as destination therapy or as a
bridge to future cardiac transplant in patients with end-stage heart failure. Extracorporeal …

Cardiogenic shock (CS) is a clinical entity that includes a wide spectrum of different
scenarios. Mechanical circulatory support (MCS) plays a fundamental role in the …